OncoTICE (bacillus calmette-guerin): Supply issue

Last Updated: 3 April 2025

Supply issue Hospital only Active

Due to a global supply issue there may be a supply issue affecting OncoTICE (Pharmacode: 799629)

3 April 2025 | Additional brand sourced

OncoTICE will continue to be supplied on allocation. We have sourced stock of an additional brand from Te Arai, SII-Onco-BCG. Stock should be available to be ordered by mid-April 2025.

Affected product

Stock is in the country and available to order. MSD continues to manage the distribution of this product due to on-going limits in availability.

Chemical: Bacillus calmette-guerin (BCG)
Presentation: Inj 2-8 x 100 million CFU
Brand: OncoTICE
Pharmacode: 799629
Subsidy: $149.37
Measure / Qty: per 1

Schedule listing for OncoTICE(external link)

How to order OncoTICE

MSD requires that hospital pharmacists:

use email (do not use electronic EDI)
contact one wholesaler only
order on the first of the month
use the subject line: NZ OncoTICE allocation
include the number of boxes requested and the name of the hospital

MSD notes that this is a request only and pharmacies may not get the quantity requested. Your monthly allocation will be determined by the wholesaler based on historical demand as a portion of the supply available.

7 February 2025 letter from MSD about OncoTICE [PDF, 114 KB]

SII-Onco-BCG

We have sourced stock of SII-Onco-BCG, to be supplied by Te Arai. It is currently listed in the Community Schedule and will be listed in the HML from 1 May 2025. Stock should be available to order from mid-April 2025.

Presentation: Inj 40 mg per ml, vial
Brand: SII-Onco-BCG
Pharmacode: 2474239
Subsidy: $176.90
Measure / Qty: per 3

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, Pharmacode) and who your wholesaler is.